Surrogacy Market Size By Type (Gestational Surrogacy, Traditional Surrogacy), By Technology (Intrauterine Insemination (IUI), In-vitro Fertilization (IVF) {Classical/Standard IVF, Intracytoplasmic Sperm Injection [ICSI]}), By Age Group (Below 35 Years, 35

Surrogacy Market Size By Type (Gestational Surrogacy, Traditional Surrogacy), By Technology (Intrauterine Insemination (IUI), In-vitro Fertilization (IVF) {Classical/Standard IVF, Intracytoplasmic Sperm Injection [ICSI]}), By Age Group (Below 35 Years, 35-37 Years, 38 - 39 Years, 40-42 Years, 43-44 Years, Over 44 Years), By Service Provider (Hospitals, Fertility Clinics), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

The global surrogacy market is slated to grow substantially through 2032 owing to the rising consumption of unhealthy food and adoption of a sedentary lifestyle which in turn leads to hormonal changes.

New technology developments, partnerships, and collaborations among the key market players are likely to promote industry expansion in the surrogacy market. For instance, in February 2022, Eqova Healthcare, a significant company in East Delhi that provides a number of medical services, was purchased by Max Healthcare. Through this acquisition, Max Healthcare will be able to provide the residents of East Delhi with high-quality healthcare while strengthening its network presence in a wide area.

The surrogacy market has been divided in terms of type, technology, age group, service provider, and region.

Based on type, the gestational surrogacy segment recorded the largest revenue in 2022 worth over $13 billion and is expected to showcase steady growth till 2032 since the majority of consumers use gestational techniques to avoid legal entanglements, which will encourage their use through the analysis timeline.

With respect to the age group, the below 35 years segment is set to witness considerable growth through the review years attributed to the fact that most surrogate mothers are under the age of 35, owing to the high treatment success rate in this age range.

On the other hand, the 38-39 years segment is speculated to propel significantly over the forthcoming timeframe fueled by the age group's fertility rate declines because of lifestyle modifications and the usage of birth control to address certain conditions. Thereby, the rising number of women preferring surrogacy technology is likely to boost market growth during the forecast timeframe. In contrast, the over 44 years segment is set to amass over $700 million market valuation by 2032 driven by the high rates of infertility among this age range. Additionally, this age group's rapid adoption of cutting-edge prenatal technology will create the potential for segmental growth.

From the regional front, the North America surrogacy market registered more than 22% revenue share in 2022 and is estimated to proliferate steadily through the analysis timeline boosted by rising healthcare costs and rising government attempts to raise public awareness of infertility and its implications. Additionally, as infertility rates rise in the US, more people will turn to surrogacy in the years to come.

Meanwhile, the Africa surrogacy industry is poised to witness approximately 26% CAGR from 2023 to 2032 credited to the population's growing awareness of infertility treatments and growing health concerns in the region.